Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancer

Figures & data

Figure 1. The entire clinical course of the patient. Light-blue color box represents the clinical course after PD catheter insertion. WBC: White blood cell, Hb: Hemoglobin, PLT: Platelet, BUN: Blood urine nitrogen, Alb: Albumin, Scr: Serum creatinine.

Table 1. Summary of peritoneal dialysis in ESRD patients with primary liver cancer.

Reference	Dozio B., 2001 [4]	Lui SL., 2003 [6]		Peng SJ., 1996 [5]			Posthuma N., 1998 [7]	Boyer A., 2017 [8]	Present report
Age (year)	70	45	65	70	80	60	42	67	68
Gender	F	M	F	M	M	F	F	M	M
Cause for ESRD	IgAN	NA	NA	NA	NA	NA	HRD	CHF	Cirrhosis
Cause for liver cancer	HCV	HBV	NA	NA	NA	HBV&HCV	OCs	NA	HS
Cirrhosis	Yes	Yes	No	No	No	Yes	No	No	Yes
Ascites	NA	NA	NA	NA	NA	NA	No	Yes	Yes
Number of tumors	3	1	1	Multi-	1	1	1	3	1
Tumor Size (cm)	two 2.8 and one 2	NA	14*10	NA	11.2*8.5*8.5	6*5*5	8*10*17	4.4 each	3.4*3.5
Histology of the tumors	HCC	HCC	BDCAC	NA	HCC	HCC	HCC	HCC	NA
Intervention	TAE	HC	HC	TAE	TAE	CT	PHx	MWA	TAE
From PD initiated to cancer detected	4 years after PD	7 years after PD	5 years after PD	1 month after PD	10 months after PD	19 months after PD	32 months after PD	7 months after PD	Nearly 1 year before PD
Dialysis outcome after cancer detected	Continued CAPD, died 1 month later	Continued CAPD	Continued CAPD	Continued CAPD, died 2 months later	Shifted to HD, died 2 months later	Shifted to HD, died 6 months later	Shifted to HD	Continued CAPD	Initiated PD, continued CAPD for 1 year

Dozio B, Scanziani R, Rovere G, et al. Hemoperitoneum in a continuous ambulatory peritoneal dialysis patient caused by a hepatocarcinoma treated with percutaneous embolization. Am J Kidney Dis. 2001;38(3):E11.

 PubMed Web of Science ®Google Scholar

Lui SL, Yip PS, Lam MF, et al. Feasibility of reinstitution of CAPD after partial hepatectomy in patients with malignant hepatic tumors. Perit Dial Int. 2003;23(5):504–506. doi: 10.1177/089686080302300519.

 PubMed Web of Science ®Google Scholar

Peng SJ, Yang CS. Hemoperitoneum in CAPD patients with hepatic tumors. Perit Dial Int. 1996;16(1):84–85. doi: 10.1177/089686089601600121.

 PubMed Web of Science ®Google Scholar

Posthuma N, van Eps RS, ter Wee PM. Hemoperitoneum due to (hepatocellular) adenoma. Perit Dial Int. 1998;18(4):446–447. doi: 10.1177/089686089801800421.

 PubMed Web of Science ®Google Scholar

Boyer A, Jegonday MA, Lanot A, et al. Percutaneous ablation for hepatocellular carcinoma and peritoneal dialysis. Perit Dial Int. 2017;37(6):656–658. +. doi: 10.3747/pdi.2017.00073.

 PubMed Web of Science ®Google Scholar